CN115160391A - 一种靶向性过氧化亚硝基荧光探针的制备和应用 - Google Patents
一种靶向性过氧化亚硝基荧光探针的制备和应用 Download PDFInfo
- Publication number
- CN115160391A CN115160391A CN202210873820.6A CN202210873820A CN115160391A CN 115160391 A CN115160391 A CN 115160391A CN 202210873820 A CN202210873820 A CN 202210873820A CN 115160391 A CN115160391 A CN 115160391A
- Authority
- CN
- China
- Prior art keywords
- fluorescent probe
- onoo
- probe
- targeted
- fluorescence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 73
- XTVRPSBYSGATQQ-UHFFFAOYSA-N 1,2-dinitrosodioxidane Chemical compound O=NOON=O XTVRPSBYSGATQQ-UHFFFAOYSA-N 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 12
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims abstract description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 claims abstract description 4
- 238000003384 imaging method Methods 0.000 claims abstract description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 230000008859 change Effects 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 238000004440 column chromatography Methods 0.000 claims description 6
- 239000012043 crude product Substances 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 239000003480 eluent Substances 0.000 claims description 4
- CMFNMSMUKZHDEY-UHFFFAOYSA-N peroxynitrous acid Chemical compound OON=O CMFNMSMUKZHDEY-UHFFFAOYSA-N 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 3
- 229910000024 caesium carbonate Inorganic materials 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 3
- 229930182830 galactose Natural products 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 238000010511 deprotection reaction Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 230000004044 response Effects 0.000 abstract description 13
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 6
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 5
- 230000035945 sensitivity Effects 0.000 abstract description 5
- 229910052760 oxygen Inorganic materials 0.000 abstract description 4
- 239000001301 oxygen Substances 0.000 abstract description 4
- 150000001413 amino acids Chemical class 0.000 abstract description 3
- 229910052717 sulfur Inorganic materials 0.000 abstract description 3
- 239000011593 sulfur Substances 0.000 abstract description 3
- ASJFVAVKAMMVFI-ZOBORPQBSA-N (4S,5R,6S)-4,5-diacetyl-6-[(1S)-1-bromo-1,2-dihydroxyethyl]-4,5,6-trihydroxyoctane-2,3,7-trione Chemical compound Br[C@@]([C@@]([C@@]([C@](C(=O)C(C)=O)(O)C(C)=O)(O)C(C)=O)(O)C(C)=O)(O)CO ASJFVAVKAMMVFI-ZOBORPQBSA-N 0.000 abstract 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 45
- 210000004027 cell Anatomy 0.000 description 22
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 12
- 238000002189 fluorescence spectrum Methods 0.000 description 9
- 230000008685 targeting Effects 0.000 description 9
- 239000002158 endotoxin Substances 0.000 description 8
- 229920006008 lipopolysaccharide Polymers 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 230000009471 action Effects 0.000 description 6
- UBDZFAGVPPMTIT-UHFFFAOYSA-N 2-aminoguanidine;hydron;chloride Chemical compound [Cl-].NC(N)=N[NH3+] UBDZFAGVPPMTIT-UHFFFAOYSA-N 0.000 description 4
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 230000005284 excitation Effects 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 102000008070 Interferon-gamma Human genes 0.000 description 3
- 108010074328 Interferon-gamma Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 229960003130 interferon gamma Drugs 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- OKKJLVBELUTLKV-VMNATFBRSA-N methanol-d1 Chemical compound [2H]OC OKKJLVBELUTLKV-VMNATFBRSA-N 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 101100136092 Drosophila melanogaster peng gene Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- XJHABGPPCLHLLV-UHFFFAOYSA-N benzo[de]isoquinoline-1,3-dione Chemical compound C1=CC(C(=O)NC2=O)=C3C2=CC=CC3=C1 XJHABGPPCLHLLV-UHFFFAOYSA-N 0.000 description 1
- 238000012984 biological imaging Methods 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 238000002784 cytotoxicity assay Methods 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000037041 intracellular level Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6447—Fluorescence; Phosphorescence by visual observation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1088—Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
Description
技术领域
本发明属于荧光探针技术领域,具体涉及一种靶向性过氧化亚硝基荧光探针的制备和应用。
背景技术
过氧化亚硝基(ONOO-)是一种重要的活性氧(ROS),是由一氧化氮(NO)和超氧阴离子(O2 .-)反应生成的产物(R.Radi,J.Biol.Chem.,2013,288,26464-26472)。作为一种强氧化剂和强亲核试剂,ONOO-能够与多种生物分子发生反应,比如蛋白质、脂质、核酸等,最终导致细胞死亡(L.Liaudet,G.Vassalli,P.Pacher,Front.Biosci.,2009,14,4809-4814)。并且,ONOO-还可作为信号分子参与信号传导过程(B.C.Dickinson,C.J.Chang,Nat.Chem.Biol.,2011,7,504-511)。此外,过氧化亚硝基的水平异常和一些常见的疾病相关,如心血管疾病、神经退行性疾病、糖尿病和炎症型肠病(J.S.Beckman,M.Carson,C.D.Smith and W.H.Koppenol,Nature,1993,364,584–585;H.Wiseman and B.Halliwell,Biochem.J.,1996,313,17–29;P.Pacher,J.S.Beckman and L.Liaudet,Physiol.Rev.,2007,87,315–424;S.M.Schieke,K.Briviba,L.O.Klotz and H.Sies,FEBS Lett.,1999,448,301–303)。由于过氧化亚硝基有着重要的生理及临床意义,因此设计有效的方法去精确检测它的含量就显得非常必要。
近年来,由于荧光探针具有操作简单,灵敏度高,对生物样品无损害、可实现的时空分辨等优点,引起了人们的广泛关注(H.Zhu,J.L.Fan,J.J.Du,X.Peng,J.Acc.Chem.Res.,2016,49,2115-2126)。到目前为止,利用ONOO-的强氧化性和亲核性,开发了许多荧光探针来检测ONOO-(J.Zhou,Y.Li,J.N.Shen,Q.Li,R.Wang,Y.F.Xu,X.H.Qian,RSC Adv.,2014,4,51589-51592;X.F.Yang,X.Q.Guo,Y.B.Zhao,Talanta.,2002,57,883-890;F.B.Yu,P.Li,B.S.Wang,K.L.Han,J.Am.Chem.Soc.,2013,135,7674-7680;T.Peng,N.K.Wong,X.Chen,Y.K.Chan,D.H.Ho,Z.Sun,J.J.Hu,J.Shen,H.EI-Nezami,D.Yang,J.Am.Chem.Soc.,2014,136,11728-11734;Z.N.Sun,H.L.Wang,F.Q.Liu,Y.Chen,P.K.H.Tam,D.Yang,Org.Lett.,2009,11,1887-1890;Y.Li,X.Xie,X.Yang,M.Li,X.Jiao,Y.Sun,X.Wang,B.Tang,Chem.Sci.,2017,8,4006-4011)。但是,这些探针存在一些问题:(1)探针的荧光团(如荧光素、萘酰亚胺、氟硼吡咯等)的发射波长较短,这限制了这些探针在生物体内的应用;(2)以前所报道的这些荧光探针大多是以单个荧光发射峰强度变化作为响应信号的,容易受到一些环境因素(如设备效率,温度,探针浓度等)的影响;(3)这些探针缺乏靶向性,这些探针没有靶向团,在细胞成像时,缺乏对炎症细胞的准确靶向识别能力,导致探针非特异性地进入正常细胞产生假阳性信号。因此,设计和合成具有长波长发射,靶向性的比率型荧光探针是非常有意义的。
半花菁染料是目前荧光探针领域中应用比较广泛的一类染料,它具有化学性质稳定、荧光量子产率高等优点。特别是,基于半花菁类的探针具有近红外发射,因此组织穿透力强,不易受到生物自体荧光的干扰,对生物成像更有利。据文献报道,半花菁类荧光探针已被用来检测pH、活性氧、生物硫醇和各种酶(L.L.Wu,Y.Wang,T.D.James,N.Q.Jia,C.S.Huang,Chem.Commun.2018,54,5518-5521;X.Xie,X.Yang,T.Wu,Y.Li,M.Li,Q.Tan,X.Wang,B.Tang,Anal.Chem.2016,88,8019-8025;C.S.Park,T.H.Ha,S.A.Choi,D.N.Nguyen,S.Noh,O.S.Kwon,C.S.Lee,H.Yoon,Biosens.Bioelectron.2017,89,919-926;S.J.Li,C.Y.Li,Y.F.Li,J.J.Fei,P.Wu,B.Yang,J.Ou-Yang,S.X.Nie,Anal.Chem.2017,89,6854-6860)。在探针中引入半乳糖结构是实现靶向炎症性肠病(IBD)的一种有效策略,探针在细胞和组织的特异性分布有望提升细胞中ONOO-检测的灵敏度和信噪比。但是,现在还没有能同时靶向IBD和检测ONOO-的荧光探针。因此,设计和合成一种基于半花菁染料的靶向性过氧亚硝基荧光探针,作为检测细胞中ONOO-的有效工具,是非常必要的。
发明内容
根据所提出的要求,本发明人对此进行了深入研究,在付出了大量创造性劳动后,提供了一种靶向性过氧化亚硝基荧光探针。
本发明的技术方案是,一种靶向性过氧化亚硝基荧光探针,其结构式如下:
一种靶向性过氧化亚硝基荧光探针的制备方法,步骤如下:
在100mL圆底烧瓶中,将1当量的Cy-OH,3~5当量的碳酸铯溶于二氯甲烷中,室温下,在氮气中搅拌10~20分钟;然后,通过注射器加入3~5当量的溴代四乙酰基半乳糖,继续在室温下搅拌10~12小时;通过减压蒸馏除去溶剂,粗产品用体积比为30:1~12:1的CH2Cl2/CH3OH洗脱剂进行柱层析,得到蓝色固体物质;随后,将其溶解在无水甲醇中,加入3~5当量的碳酸钾脱保护,在室温下搅拌反应混合物2~3小时;然后,减压蒸馏除去溶剂,所得粗产品用体积比为15:1~10:1的CH2Cl2/CH3OH洗脱剂柱层析分离得到蓝色固体Cy-Gal,即为荧光探针。
本发明的有益效果是,一种靶向性过氧化亚硝基荧光探针的良好性能。首先,研究了该探针的荧光光谱性质,加入ONOO-之前,荧光探针有近红外(717nm)的荧光发射峰;加入ONOO-之后,在可见区(477nm)出现了蓝色发射峰。并且随着ONOO-浓度的增大,探针分子的近红外荧光强度不断降低,蓝色荧光强度不断增强。当加入40μM的ONOO-时,荧光强度比值(F477/F717)增强872倍,因此可以比率检测ONOO-。该探针的检测范围从1.0μM到40.0μM,检测限为0.06μM,这说明该探针可以高灵敏的检测ONOO-。其次,研究了探针的紫外吸收光谱,在没有加入ONOO-时,探针在680nm处有吸收带;加入ONOO-后,680nm处的吸收峰减小,在345nm附近出现新的吸收峰,溶液颜色从蓝色变为无色。接着,研究了探针的选择性,考察了探针与活性氧(ClO-,H2O2),活性氮(NO2 -,NO3 -),活性硫(SO3 2-,HSO3 -),生物硫醇(Cys,Hcy,GSH)以及常见氨基酸(Met,Lys,Trp,Phe,Thr,Ile,Leu,Val)的荧光响应情况。结果发现,只有ONOO-能引起荧光光谱的改变,其他检测物对探针的荧光光谱没有明显的影响。最后,研究了pH值对荧光探针测定ONOO-的影响,当pH值在6.0到8.6之间时,不影响荧光探针对ONOO-的测定。此外,该荧光探针响应较快,响应时间在15min以内。
一种靶向性过氧化亚硝基荧光探针的应用。在细胞中加入荧光探针,红色通道可以观察到的较强的荧光,而在蓝色通道几乎没有荧光,这说明细胞中的ONOO-较低。细胞用脂多糖(LPS)和干扰素-γ(IFN-γ)处理,然后用探针染色,发现蓝色通道荧光明显增强,而红色通道荧光减弱;用氨基胍盐酸盐(AG)处理抑制细胞内ONOO-的产生,发现蓝色通道的荧光减弱,红色通道的荧光增强。这些结果说明荧光探针Cy-Gal能监控细胞内ONOO-含量的变化,这为监控人体内和过氧化亚硝基相关病变提供一种可靠的手段。
附图说明
图1为荧光探针的合成路线。
图2为荧光探针与不同浓度的ONOO-作用后的荧光光谱图。
横坐标为波长,纵坐标为荧光强度。荧光探针的浓度均为10μM,ONOO-浓度分别为:0,1.0,2.0,3.0,4.0,5.0,7.5,10.0,12.5,15.0,20.0,22.5,25.0,27.5,30.0,32.5,35.0,37.5,40.0μM。发射波长为717nm对应的激发波长为680nm,发射波长为477nm对应的激发波长为345nm。
图3为荧光探针对不同ONOO-浓度的荧光线性响应图。
图4为荧光探针与ONOO-作用后的紫外可见吸收光谱图。
横坐标为波长,纵坐标为吸光度。荧光探针的浓度为10μM,ONOO-浓度为40μM。
图5为荧光探针的选择性图。
荧光探针的浓度均为10μM,ONOO-浓度为40μM,其它分析物浓度均为200μM。
图6为pH对荧光探针的影响图。
图7为荧光探针与ONOO-作用后荧光强度随时间变化的关系曲线图。
图8为细胞毒性试验。横坐标为荧光探针的浓度,纵坐标为细胞的存活率。
图9荧光探针与ONOO-作用的细胞成像图。(a)细胞用探针染色0.5h。(b)细胞用LPS和IFN-γ处理10h,然后用探针染色0.5h。(c)细胞用LPS、IFN-γ和AG处理10h,然后用探针染色0.5h。(d)相对荧光强度图。
具体实施方式
下面结合附图和具体实施例对本发明进行详细说明,但不限于此。
实施例1:
荧光探针的合成
合成路线如图1。在100mL圆底烧瓶中,将1当量的Cy-OH,4当量的碳酸铯溶于二氯甲烷中,室温下,在氮气中搅拌15分钟;然后,通过注射器加入4当量的溴代四乙酰基半乳糖,继续在室温下搅拌12小时;通过减压蒸馏除去溶剂,粗产品用体积比为12:1的CH2Cl2/CH3OH洗脱剂进行柱层析,得到蓝色固体物质;随后,将其溶解在无水甲醇中,加入4当量的碳酸钾脱保护,在室温下搅拌反应混合物2小时;然后,减压蒸馏除去溶剂,所得粗产品用体积比为10:1的CH2Cl2/CH3OH洗脱剂柱层析分离得到蓝色固体Cy-Gal(产率60%),即为荧光探针。1H NMR(400MHz,MeOD)δ8.77(d,J=15.4Hz,1H),7.70(d,J=7.3Hz,1H),7.62–7.50(m,2H),7.50–7.42(m,2H),7.35(s,1H),7.20(s,1H),7.10(d,J=8.3Hz,1H),6.54(d,J=15.0Hz,1H),5.03(d,J=7.7Hz,1H),4.43(d,J=7.3Hz,2H),3.98(d,J=3.2Hz,1H),3.85(d,J=9.2Hz,3H),3.66(d,J=4.8Hz,1H),2.86–2.63(m,4H),1.92(d,J=6.7Hz,2H),1.83(d,J=8.5Hz,5H),1.49(t,J=7.2Hz,3H),1.28(d,J=3.7Hz,5H).13C NMR(100MHz,MeOD)δ178.5,161.7,154.7,146.8,143.1,141.8,133.7,130.2,129.4,127.9,125.9,118.3,117.6,115.3,113.2,104.2,102.3,76.8,74.1,71.4,69.6,62.0,51.5,41.0,32.4,29.5,27.6,41.6,24.3,23.0,20.9,13.8,12.3.
实施例2:
荧光探针和ONOO-溶液配制
探针溶液的制备:称取一定量探针溶解在DMSO中,配成4×10-4M的探针溶液。ONOO-溶液的配制:将0.70M的H2O2溶液、0.60M的HCl溶液、0.60M的NaNO2溶液混合,并迅速加入1.5M的NaOH溶液,过量的H2O2用二氧化锰除去,保存在-20℃的冷冻环境中。使用前化冻使用,ONOO-浓度的确定,需要测定该溶液在302nm处的吸光度A,计算公式为:CONOO -=A/1.67(mM)。
实施例3:
荧光探针与ONOO-作用的荧光光谱的测定
图2为荧光探针与ONOO-作用的荧光光谱,荧光探针的浓度为10μM,ONOO-的浓度依次为0,1.0,2.0,3.0,4.0,5.0,7.5,10,12.5,15,20,22.5,25,27.5,30,32.5,35,37.5,40μM。第一个激发波长为680nm,发射波长范围为693~850nm;第二个激发波长为345nm,发射波长范围为400~520nm。狭缝宽度为5.0nm/5.0nm,所用的荧光测定仪器为日立F4600荧光分光光度计。从图2可以看出,加入ONOO-之前,荧光探针有近红外(717nm)的荧光发射峰;加入ONOO-之后,在可见区(477nm)出现了蓝色发射峰。这是因为探针分子被ONOO-氧化,导致断裂,共轭结构变小,从而产生短波长的蓝色荧光。并且,随着ONOO-浓度的增大,探针分子的近红外荧光强度不断降低,蓝色荧光强度不断增强。当加入30μM的ONOO-时,荧光强度比值(F477/F717)增强872倍,因此可以比率检测ONOO-。图3为探针对不同ONOO-浓度的线性响应图。荧光强度跟ONOO-的浓度呈现线性关系,线性范围是1.0μM~40.0μM,检测限是0.06μM。这说明该探针可以高灵敏的检测ONOO-。
实施例4:
荧光探针与ONOO-作用的紫外可见吸收光谱的测定
图4为荧光探针与ONOO-作用后的紫外可见吸收光谱图,荧光探针的浓度为10μM,ONOO-的浓度为40μM。紫外可见吸收光谱测定用的仪器为安捷伦Cary60紫外可见分光光度计。从图2中可以看出,在没有加入ONOO-时,探针在680nm处有吸收带;加入ONOO-后,680nm处的吸收峰减小,在345nm附近出现新的吸收峰,溶液颜色从蓝色变为无色。
实施例5:
荧光探针对ONOO-测定的选择性
图5为荧光探针对ONOO-测定的选择性图。考察在浓度为10μM的荧光探针溶液中加入ONOO-(40μM)及其与活性氧(ClO-,H2O2),活性氮(NO2 -,NO3 -),活性硫(SO3 2-,HSO3 -),生物硫醇(Cys,Hcy,GSH)以及常见氨基酸(Met,Lys,Trp,Phe,Thr,Ile,Leu,Val)(200μM)的荧光响应情况。从图5中可以看出,只有ONOO-能引起荧光光谱的改变,其他检测物对探针的荧光光谱没有明显的影响。这些结果表明,荧光探针对ONOO-有较好的选择性。
实施例6:
溶液pH值对荧光探针测定ONOO-的荧光性质的影响
考察pH值对荧光探针测定ONOO-的荧光光谱的影响,其结果如图6。我们研究的pH范围为4.5~10.0,荧光探针的浓度为10μM,ONOO-的浓度为40μM。从图中可以看出,荧光探针随着pH的变化,荧光强度比值(F477/F717)基本不变,说明pH对探针本身没有很大的影响。然而,加入ONOO-之后,当pH<6时,荧光强度随pH的下降而降低;当pH为6.0~8.6范围时,荧光强度比值基本不变;当pH>8.6时。荧光强度比值逐渐下降。综上所述,当pH值在6.0到8.6之间时,不影响荧光探针对ONOO-的测定,是比较合适的pH值范围,这非常有利于该探针用于实际样品中ONOO-的测定。
实施例7:
荧光探针与ONOO-作用的响应时间的测定
我们研究了荧光探针对ONOO-的响应时间,其结果如图7。从图中可以看出,该探针对ONOO-的响应时间为15min,这能够满足在实际样品中进行实时监测时对响应时间的要求。从图7我们还可以看出,荧光强度达到最大值后,在之后的时间里,荧光强度不再发生变化,这表明此荧光探针光稳定性较好。
实施例8:
荧光探针在活细胞中的应用
首先,我们做了细胞毒性试验,如图8所示。当加入0~40μM ONOO-探针,细胞的成活率均在90%以上,因此可以说明,该荧光探针毒性较小,可应用于检测活细胞内的ONOO-。然后,我们研究荧光探针在活细胞中的应用,选择HepG2细胞进行共聚焦显微成像,结果如图9所示。在细胞中加入荧光探针,红色通道可以观察到的较强的荧光,而在蓝色通道几乎没有荧光,这说明细胞中的ONOO-较低(图9a)。文献报道脂多糖(LPS)和干扰素-γ(IFN-γ)可以共同刺激肝癌细胞释放OONO-。细胞用LPS和IFN-γ预先处理10h,然后用探针染色0.5h,蓝色通道荧光明显增强,而红色通道荧光减弱(图9b);细胞用LPS、IFN-γ和AG处理10h,然后用探针染色0.5h,蓝色通道的荧光减弱,红色通道的荧光增强(图9c)。图9d为相对荧光强度图,这些结果说明荧光探针能监控细胞内ONOO-含量的变化,为监控人体内和过氧化亚硝基相关病变提供一种可靠的手段。
Claims (3)
2.根据权利要求1所述的一种靶向性过氧化亚硝基荧光探针的制备方法,其特征在于,反应步骤如下:
在100mL圆底烧瓶中,将1当量的Cy-OH,3~5当量的碳酸铯溶于二氯甲烷中,室温下,在氮气中搅拌10~20分钟;然后,通过注射器加入3~5当量的溴代四乙酰基半乳糖,继续在室温下搅拌10~12小时;通过减压蒸馏除去溶剂,粗产品用体积比为30:1~12:1的CH2Cl2/CH3OH洗脱剂进行柱层析,得到蓝色固体物质;随后,将其溶解在无水甲醇中,加入3~5当量的碳酸钾脱保护,在室温下搅拌反应混合物2~3小时;然后,减压蒸馏除去溶剂,所得粗产品用体积比为15:1~10:1的CH2Cl2/CH3OH洗脱剂柱层析分离得到蓝色固体Cy-Gal,即为荧光探针。
3.根据权利要求1所述的一种靶向性过氧化亚硝基荧光探针的应用,其特征在于,所述荧光探针已应用于细胞成像研究,可以检测细胞内过氧化亚硝基含量的变化。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210873820.6A CN115160391B (zh) | 2022-07-20 | 一种靶向性过氧化亚硝基荧光探针的制备和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210873820.6A CN115160391B (zh) | 2022-07-20 | 一种靶向性过氧化亚硝基荧光探针的制备和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115160391A true CN115160391A (zh) | 2022-10-11 |
CN115160391B CN115160391B (zh) | 2024-04-26 |
Family
ID=
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150011878A1 (en) * | 2013-07-02 | 2015-01-08 | The Board Of Trustees Of The Leland Stanford Junior University | Discrete imaging of hepatic oxidative and nitrosative stress with two-channel nanoparticles for in vivo drug safety screening |
CN107937481A (zh) * | 2017-09-07 | 2018-04-20 | 大连医科大学 | 一种β‑葡萄糖醛酸苷酶的含吲哚基的荧光探针及其应用 |
CN109897080A (zh) * | 2019-03-14 | 2019-06-18 | 济南大学 | 高选择超灵敏肝癌特异性过氧化亚硝酸盐探针及其应用 |
CN110746437A (zh) * | 2019-10-22 | 2020-02-04 | 湘潭大学 | 基于吡喃-香豆素的一氧化碳荧光探针的制备和应用 |
CN110845556A (zh) * | 2019-11-27 | 2020-02-28 | 济南大学 | 一种靶向肿瘤β-半乳糖苷酶近红外荧光探针及其制备方法 |
CN113801105A (zh) * | 2021-09-30 | 2021-12-17 | 山西医科大学第一医院 | 线粒体靶向的过氧亚硝酸根/亚硫酸氢根双响应荧光探针 |
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150011878A1 (en) * | 2013-07-02 | 2015-01-08 | The Board Of Trustees Of The Leland Stanford Junior University | Discrete imaging of hepatic oxidative and nitrosative stress with two-channel nanoparticles for in vivo drug safety screening |
CN107937481A (zh) * | 2017-09-07 | 2018-04-20 | 大连医科大学 | 一种β‑葡萄糖醛酸苷酶的含吲哚基的荧光探针及其应用 |
CN109897080A (zh) * | 2019-03-14 | 2019-06-18 | 济南大学 | 高选择超灵敏肝癌特异性过氧化亚硝酸盐探针及其应用 |
CN110746437A (zh) * | 2019-10-22 | 2020-02-04 | 湘潭大学 | 基于吡喃-香豆素的一氧化碳荧光探针的制备和应用 |
CN110845556A (zh) * | 2019-11-27 | 2020-02-28 | 济南大学 | 一种靶向肿瘤β-半乳糖苷酶近红外荧光探针及其制备方法 |
CN113801105A (zh) * | 2021-09-30 | 2021-12-17 | 山西医科大学第一医院 | 线粒体靶向的过氧亚硝酸根/亚硫酸氢根双响应荧光探针 |
Non-Patent Citations (4)
Title |
---|
WANG, YING,等: "Real-time imaging of senescence in tumors with DNA damage", 《SCIENTIFIC REPORTS》, vol. 9, no. 1, 14 February 2019 (2019-02-14), pages 1 - 11 * |
XIAOJIE TANG,等: "A new metal-free near-infrared fl uorescent probe based on nitrofuran for the detection and bioimaging o f carbon monoxide releasing molecule-2in vivo", 《ANALYST》, vol. 147, pages 268 - 273 * |
ZENG, QIN,等: "Photoacoustic nanoprobe for β-galactosidase activity detection and imaging in vivo", 《JOURNAL OF INNOVATIVE OPTICAL HEALTH SCIENCES 》, vol. 12, no. 3, 27 February 2019 (2019-02-27), pages 1941001, XP055816984, DOI: 10.1142/S1793545819410013 * |
ZHEN, XU,等: "Macrotheranostic Probe with Disease-Activated Near-Infrared Fluorescence, Photoacoustic, and Photothermal Signals for Imaging-Guided Therapy", 《ANGEWANDTE CHEMIE, INTERNATIONAL EDITION 》, vol. 57, no. 26, 24 May 2018 (2018-05-24), pages 7804 - 7808, XP055729136, DOI: 10.1002/anie.201803321 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108219510B (zh) | 基于半花菁染料的过氧化亚硝基荧光探针的制备和应用 | |
CN110540837B (zh) | 一种过氧化氢近红外荧光探针的制备和应用 | |
CN110128435B (zh) | 一种过氧化亚硝基比率型荧光探针的制备和应用 | |
Zhao et al. | Transforming the recognition site of 4-hydroxyaniline into 4-methoxyaniline grafted onto a BODIPY core switches the selective detection of peroxynitrite to hypochlorous acid | |
CN113801105B (zh) | 线粒体靶向的过氧亚硝酸根/亚硫酸氢根双响应荧光探针 | |
CN111518083A (zh) | 一种检测一氧化碳的打开型荧光探针的制备和应用 | |
Liang et al. | A new lysosome-targetable fluorescent probe for detection of endogenous hydrogen polysulfides in living cells and inflamed mouse model | |
CN111825718B (zh) | 基于喹啉-氧杂蒽的碱性磷酸酶荧光探针的制备和应用 | |
CN109021000B (zh) | 一种检测过氧化氢的荧光探针、合成方法和应用 | |
CN110669503B (zh) | 一种一氧化碳近红外荧光探针的制备和应用 | |
CN110746437B (zh) | 基于吡喃-香豆素的一氧化碳荧光探针的制备和应用 | |
CN110642857B (zh) | 一种用于检测粘度和pH的双功能荧光探针及其制备与应用 | |
CN115160391B (zh) | 一种靶向性过氧化亚硝基荧光探针的制备和应用 | |
CN115160391A (zh) | 一种靶向性过氧化亚硝基荧光探针的制备和应用 | |
CN113200975B (zh) | 基于靛红衍生物专一响应onoo-的水溶性荧光探针、制备方法及应用 | |
CN114634464A (zh) | 一种用于检测次氯酸的溶酶体靶向近红外荧光探针及其制备方法和应用 | |
CN112285087B (zh) | 基于Au-Se界面的超灵敏高保真SERS传感器的制备及在生物小分子定量检测的应用 | |
CN113024504A (zh) | 基于异佛尔酮-氧杂蒽的硫化氢荧光探针的制备和应用 | |
CN115197204B (zh) | 基于噻吩-氧杂蒽染料的硫化氢荧光探针的制备和应用 | |
CN113429389B (zh) | 一种检测一氧化碳的固态荧光探针的制备和应用 | |
CN114605432B (zh) | 基于花菁染料的靶向性半胱氨酸荧光探针的制备和应用 | |
CN115894427B (zh) | 近红外频率上转换荧光探针及其制备方法和在检测生物硫醇中的应用 | |
Wang et al. | A novel NIR fluorescent probe with ratiometric imaging of cysteine in endoplasmic reticulum | |
CN112457360B (zh) | 一种肝靶向的过氧亚硝酸根荧光探针及制备方法和应用 | |
CN115043893B (zh) | 一种肝细胞靶向的次氯酸近红外荧光探针及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant |